Valuation: Cellnovo

Market Cap 24.36L 21.85L 19.96L 18.22L 34.34L 23Cr 35.42L 2.41Cr 95.96L 12Cr 91.42L 89.46L 39Cr P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 1.25Cr 1.12Cr 1.02Cr 93.22L 1.76Cr 117.11Cr 1.81Cr 12Cr 4.91Cr 62Cr 4.68Cr 4.58Cr 197.26Cr EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26.79L
-0.99%+1.67%+6.80%+46.09% 3,94000Cr
+3.48%-12.89%-9.86%+767.39% 39TCr
+0.82%-11.15%-51.48%+3.36% 36TCr
+1.79%+1.97%-0.74%+59.33% 27TCr
-0.26%-14.22%+47.84%+160.36% 26TCr
-0.14%-13.39%+60.72%+347.61% 22TCr
+9.86%+71.21%-36.89%+875.12% 13TCr
-0.38%-3.00%-40.84%-18.47% 11TCr
-2.90%-4.37%-26.81%-59.12% 9.31TCr
Average +1.14%+1.36%-5.70%+242.41% 57.68TCr
Weighted average by Cap. -0.15%-0.11%+3.18%+124.82%

Financials

2018 2019 *
Net sales 33.22L 29.79L 27.23L 24.86L 46.83L 31Cr 48.31L 3.28Cr 1.31Cr 17Cr 1.25Cr 1.22Cr 53Cr -
Net income -1.59Cr -1.43Cr -1.31Cr -1.19Cr -2.25Cr -149.83Cr -2.32Cr -16Cr -6.28Cr -80Cr -5.98Cr -5.85Cr -252.38Cr -
Net Debt 1Cr 89.89L 82.15L 74.99L 1.41Cr 94Cr 1.46Cr 9.9Cr 3.95Cr 50Cr 3.76Cr 3.68Cr 158.69Cr -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock